Plasma pTau181 and biomarker combinations to identify Alzheimer´s disease at any stage along the AD continuum compared with both controls and non‐AD dementia
Year: 2023
Type: article
Study design: Observational Study
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.077504
Authors: James D Doecke, Giovanni Bellomo, Lisa Vermunt, Daniel Alcolea, Steffen Halbgebauer, Sjors G.J.G. in ’t Veld, Niklas Mattsson‐Carlgren, Katerina Veverova, Christopher J Fowler, Lynn Boonkamp, Marleen Koel‐Simmerlink, Zulaiga Hussainali, Daimy N. Ruiters, Lorenzo Gaetani, Andrea Toja, Juan Fortea, Yolande A.L. Pijnenburg, Afina W. Lemstra, Wiesje M. van der Flier, Jakub Hort, Markus Otto, Oskar Hansson, Lucilla Parnetti, Colin L Masters, Alberto Lleó, Marta del Campo, Charlotte E. Teunissen
Institutions: Commonwealth Scientific and Industrial Research Organisation, Australian e-Health Research Centre, University of Perugia, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam UMC Location Vrije Universiteit Amsterdam, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Universität Ulm, Vrije Universiteit Amsterdam, Lund University, Charles University, University Hospital in Motol, The University of Melbourne, Florey Institute of Neuroscience and Mental Health, Institut de Recerca Sant Pau, University Hospital Ulm, Universidad San Pablo CEU, Pasqual Maragall Foundation, Barcelonaβeta Brain Research Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4390195264